Invention Grant
- Patent Title: Onapristone extended-release compositions and methods
-
Application No.: US17035544Application Date: 2020-09-28
-
Publication No.: US11672762B2Publication Date: 2023-06-13
- Inventor: Alexander Zukiwski , Stefan Proniuk
- Applicant: Context Biopharma Inc.
- Assignee: CONTEXT BIOPHARMA, INC.
- Current Assignee: CONTEXT BIOPHARMA, INC.
- Current Assignee Address: US PA Philadelphia
- Agency: Goodwin Procter LLP
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K31/575
Abstract:
Onapristone extended-release formulations and methods of administering onapristone extended-release formulations are provided. Onapristone extended-release formulations provide sufficient therapeutic activity as compared to immediate-release formulations with reduced potential for adverse side effects.
Public/Granted literature
- US20210220279A1 ONAPRISTONE EXTENDED-RELEASE COMPOSITIONS AND METHODS Public/Granted day:2021-07-22
Information query
